Trinity Biotech plcTT

Trinity Biotech plc

0.6255USDR
−0.0701−10.08%
As of today at 16:41 GMT
USD
No trades
See on Supercharts

TRIB fundamentals

Key facts

Market capitalization‪7.91 M‬USD
Basic EPS (TTM)−2.26USD
Founded1992
CEOJohn Gillard
About

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Ownership
‪‪11.37 M‬‬
Free Float shares
‪‪10.96 M‬‬ (96.43%)
Closely held shares
‪‪405.72 K‬‬ (3.57%)
Free Float shares
‪‪10.96 M‬‬ (96.43%)
Closely held shares
‪‪405.72 K‬‬ (3.57%)
Capital structure
Market cap
‪‪7.91 M‬‬
Debt
‪‪93.72 M‬‬
Cash & equivalents
‪‪2.84 M‬‬
Enterprise value
‪‪98.78 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪7.91 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.12x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.12x
Valuation ratios
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪0.12‬
‪0.24‬
‪0.36‬
‪0.48‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−48%‬
‪−41%‬
‪−34%‬
‪−27%‬
‪−20%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−7.00 M‬‬
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
‪‪21.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−5.50 M‬‬
‪0.00‬
‪‪5.50 M‬‬
‪‪11.00 M‬‬
‪‪16.50 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−5.50 M‬‬
‪0.00‬
‪‪5.50 M‬‬
‪‪11.00 M‬‬
‪‪16.50 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Clinical Laboratory Goods
Point-of-Care
Clinical Laboratory Services
By country
Period: 2023
Americas
Ireland

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪4.50 M‬‬
‪‪9.00 M‬‬
‪‪13.50 M‬‬
‪‪18.00 M‬‬
Actual
Estimate
Earnings
Next:Apr 2, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−0.80‬
‪−0.60‬
‪−0.40‬
‪−0.20‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

TRIB does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−35.00 M‬‬
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
‪‪100.00 M‬‬
Assets
Liabilities